1
|
Reddy PH, Manczak M, Mao P, Calkins MJ,
Reddy AP and Shirendeb U: Amyloid-beta and mitochondria in aging
and Alzheimer's disease: Implications for synaptic damage and
cognitive decline. J Alzheimers Dis. 20 (Suppl 2):S499–S512. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Mattson MP: Pathways towards and away from
Alzheimer's disease. Nature. 430:631–639. 2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Vaz M and Silvestre S: Alzheimer's
disease: Recent treatment strategies. Eur J Pharmacol.
887:1735542020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Reddy PH, Manczak M and Yin X:
Mitochondria-division inhibitor 1 protects against amyloid-β
induced mitochondrial fragmentation and synaptic damage in
Alzheimer's disease. J Alzheimers Dis. 58:147–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pozueta J, Lefort R and Shelanski ML:
Synaptic changes in Alzheimer's disease and its models.
Neuroscience. 251:51–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Koffie RM, Hyman BT and Spires-Jones TL:
Alzheimer's disease: Synapses gone cold. Mol Neurodegener.
6:632011. View Article : Google Scholar : PubMed/NCBI
|
7
|
DeKosky ST and Scheff SW: Synapse loss in
frontal cortex biopsies in Alzheimer's disease: Correlation with
cognitive severity. Ann Neurol. 27:457–464. 1990. View Article : Google Scholar : PubMed/NCBI
|
8
|
Terry RD, Masliah E, Salmon DP, Butters N,
DeTeresa R, Hill R, Hansen LA and Katzman R: Physical basis of
cognitive alterations in Alzheimer's disease: Synapse loss is the
major correlate of cognitive impairment. Ann Neurol. 30:572–580.
1991. View Article : Google Scholar : PubMed/NCBI
|
9
|
Harris KM and Kater SB: Dendritic spines:
Cellular specializations impartingboth stability and flexibility to
synaptic function. Annu Rev Neurosci. 17:341–371. 1994. View Article : Google Scholar : PubMed/NCBI
|
10
|
Carlisle HJ and Kennedy MB: Spine
architecture and synaptic plasticity. Trends Neurosci. 28:182–187.
2005. View Article : Google Scholar : PubMed/NCBI
|
11
|
Serrano-Pozo A, Frosch MP, Masliah E and
Hyman BT: Neuropathological alterations in Alzheimer disease. Cold
Spring Harb Perspect Med. 1:a0061892011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ryu J, Hong BH, Kim YJ, Yang EJ, Choi M,
Kim H, Ahn S, Baik TK, Woo RS and Kim HS: Neuregulin-1 attenuates
cognitive function impairments in a transgenic mouse model of
Alzheimer's disease. Cell Death Dis. 7:e21172016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Colgan LA and Yasuda R: Plasticity of
dendritic spines: Subcompartmentalization of signaling. Annu Rev
Physiol. 76:365–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jankowsky JL and Zheng H: Practical
considerations for choosing a mouse model of Alzheimer's disease.
Mol Neurodegener. 12:892017. View Article : Google Scholar : PubMed/NCBI
|
15
|
Barage SH and Sonawane KD: Amyloid cascade
hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's
disease. Neuropeptides. 52:1–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Shah K and Lahiri DK: Cdk5 activity in the
brain-multiple paths of regulation. J Cell Sci. 127:2391–2400.
2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Nguyen MD, Larivière RC and Julien JP:
Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated
by perikaryal neurofilament inclusions. Neuron. 30:135–147. 2001.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Meuer K, Suppanz IE, Lingor P, Planchamp
V, Göricke B, Fichtner L, Braus GH, Dietz GP, Jakobs S, Bähr M and
Weishaupt JH: Cyclin-dependent kinase 5 is an upstream regulator of
mitochondrial fission during neuronal apoptosis. Cell Death Differ.
14:651–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Guo MY, Shang L, Hu YY, Jiang LP, Wan YY,
Zhou QQ, Zhang K, Liao HF, Yi JL and Han XJ: The role of
Cdk5-mediated Drp1 phosphorylation in Aβ1–42 induced
mitochondrial fission and neuronal apoptosis. J Cell Biochem.
119:4815–4825. 2018. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yan M, Guo A, Chen P, Jing H, Ren D, Zhong
Y, Wu Y, Fei E, Lai X, Zou S and Wang S: LRP4 LDLα repeats of
astrocyte enhance dendrite arborization of the neuron. Mol Brain.
13:1662020. View Article : Google Scholar : PubMed/NCBI
|
21
|
Kandimalla R, Manczak M, Yin X, Wang R and
Reddy PH: Hippocampal phosphorylated tau induced cognitive decline,
dendritic spine loss and mitochondrial abnormalities in a mouse
model of Alzheimer's disease. Hum Mol Genet. 27:30–40. 2018.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Ingelsson M, Fukumoto H, Newell KL,
Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT and
Irizarry MC: Early Abeta accumulation and progressive synaptic
loss, gliosis and tangle formation in AD brain. Neurology.
62:925–931. 2004. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lista S and Hampel H: Synaptic
degeneration and neurogranin in the pathophysiology of Alzheimer's
disease. Expert Rev Neurother. 17:47–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Deshpande A, Mina E, Glabe C and Busciglio
J: Different conformations of amyloid beta induce neurotoxicity by
distinct mechanisms in human cortical neurons. J Neurosci.
26:6011–6018. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Cummings BJ, Su JH, Geddes JW, Van
Nostrand WE, Wagner SL, Cunningham DD and Cotman CW: Aggregation of
the amyloid precursor protein within degenerating neurons and
dystrophic neurites in Alzheimer's disease. Neuroscience.
48:763–777. 1992. View Article : Google Scholar : PubMed/NCBI
|
26
|
Grutzendler J, Helmin K, Tsai J and Gan
WB: Various dendritic abnormalities are associated with fibrillar
amyloid deposits in Alzheimer's disease. Ann N Y Acad Sci.
1097:30–39. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Tsai J, Grutzendler J, Duff K and Gan WB:
Fibrillar amyloid deposition leads to local synaptic abnormalities
and breakage of neuronal branches. Nat Neurosci. 7:1181–1183. 2004.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Walsh DM, Klyubin I, Fadeeva JV, Cullen
WK, Anwyl R, Wolfe MS, Rowan MJ and Selkoe DJ: Naturally secreted
oligomers of amyloid beta protein potently inhibit hippocampal
long-term potentiation in vivo. Nature. 416:535–539. 2002.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Busche MA, Eichhoff G, Adelsberger H,
Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A and
Garaschuk O: Clusters of hyperactive neurons near amyloid plaques
in a mouse model of Alzheimer's disease. Science. 321:1686–1689.
2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Masliah E, Ellisman M, Carragher B,
Mallory M, Young S, Hansen L, DeTeresa R and Terry RD:
Three-dimensional analysis of the relationship between synaptic
pathology and neuropil threads in Alzheimer disease. J Neuropathol
Exp Neurol. 51:404–414. 1992. View Article : Google Scholar : PubMed/NCBI
|
31
|
Postuma RB, He W, Nunan J, Beyreuther K,
Masters CL, Barrow CJ and Small DH: Substrate-bound beta-amyloid
peptides inhibit cell adhesion and neurite outgrowth in primary
neuronal cultures. J Neurochem. 74:1122–1130. 2000. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wilkaniec A, Gąssowska-Dobrowolska M,
Strawski M, Adamczyk A and Czapski GA: Inhibition of
cyclin-dependent kinase 5 affects early neuroinflammatory
signalling in murine model of amyloid beta toxicity. J
Neuroinflammation. 15:12018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Huang E, Qu D, Zhang Y, Venderova K, Haque
ME, Rousseaux MW, Slack RS, Woulfe JM and Park DS: The role of
Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation
in neuronal death. Nat Cell Biol. 12:563–571. 2010. View Article : Google Scholar : PubMed/NCBI
|
34
|
Taguchi N, Ishihara N, Jofuku A, Oka T and
Mihara K: Mitotic phosphorylation of dynamin-related GTPase Drp1
participates in mitochondrial fission. J Biol Chem.
282:11521–11529. 2007. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhang WY, Gu ZL, Liang ZQ and Qin ZH:
Mitochondrial dysfunction and Huntington disease. Neurosci Bull.
22:129–136. 2006.PubMed/NCBI
|
36
|
Baloyannis SJ: Mitochondrial alterations
in Alzheimer's disease. J Alzheimers Dis. 9:119–126. 2006.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Cho DH, Nakamura T, Fang J, Cieplak P,
Godzik A, Gu Z and Lipton SA: S-nitrosylation of Drp1 mediates
beta-amyloid-related mitochondrial fission and neuronal injury.
Science. 324:102–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
38
|
Kim H, Scimia MC, Wilkinson D, Trelles RD,
Wood MR, Bowtell D, Dillin A, Mercola M and Ronai ZA: Fine-tuning
of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial
adaptation to hypoxia. Mol Cell. 44:532–544. 2011. View Article : Google Scholar : PubMed/NCBI
|
39
|
Chandhok G, Lazarou M and Neumann B:
Structure, function and regulation of mitofusin-2 in health and
disease. Biol Rev Camb Philos Soc. 93:933–949. 2018. View Article : Google Scholar : PubMed/NCBI
|
40
|
Yan QW, Zhao N, Xia J, Li BX and Yin LY:
Effects of treadmill exercise on mitochondrial fusion and fission
in the hippocampus of APP/PS1 mice. Neurosci Lett. 701:84–91. 2019.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Wang X, Su B, Lee HG, Li X, Perry G, Smith
MA and Zhu X: Impaired balance of mitochondrial fission and fusion
in Alzheimer's disease. J Neurosci. 29:9090–9103. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Qi X, Qvit N, Su YC and Mochly-Rosen D: A
novel Drp1 inhibitor diminishes aberrant mitochondrial fission and
neurotoxicity. J Cell Sci. 126:789–802. 2013.PubMed/NCBI
|
43
|
Han XJ, Lu YF, Li SA, Kaitsuka T, Sato Y,
Tomizawa K, Nairn AC, Takei K, Matsui H and Matsushita M: CaM
kinase I alpha-induced phosphorylation of Drp1 regulates
mitochondrial morphology. J Cell Biol. 182:573–585. 2008.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Cereghetti GM, Stangherlin A, Martins de
Brito O, Chang CR, Blackstone C, Bernardi P and Scorrano L:
Dephosphorylation by calcineurin regulates translocation of Drp1 to
mitochondria. Proc Natl Acad Sci USA. 105:15803–15808. 2008.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Yan J, Liu XH, Han MZ, Wang YM, Sun XL, Yu
N, Li T, Su B and Chen ZY: Blockage of GSK3β-mediated Drp1
phosphorylation provides neuroprotection in neuronal and mouse
models of Alzheimer's disease. Neurobiol Aging. 36:211–227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
46
|
Cho B, Cho HM, Kim HJ, Jeong J, Park SK,
Hwang EM, Park JY, Kim WR, Kim H and Sun W: CDK5-dependent
inhibitory phosphorylation of Drp1 during neuronal maturation. Exp
Mol Med. 46:e1052014. View Article : Google Scholar : PubMed/NCBI
|
47
|
Jahani-Asl A, Huang E, Irrcher I,
Rashidian J, Ishihara N, Lagace DC, Slack RS and Park DS: CDK5
phosphorylates DRP1 and drives mitochondrial defects in
NMDA-induced neuronal death. Hum Mol Genet. 24:4573–4583. 2015.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Nakamura T, Cieplak P, Cho DH, Godzik A
and Lipton SA: S-nitrosylation of Drp1 links excessive
mitochondrial fission to neuronal injury in neurodegeneration.
Mitochondrion. 10:573–578. 2010. View Article : Google Scholar : PubMed/NCBI
|